کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
5667213 1592034 2017 6 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Receipt of thyroid hormone deficiency treatment and risk of herpes zoster
ترجمه فارسی عنوان
دریافت درمان کمبود هورمون تیروئید و خطر ابتلا به تبخال
کلمات کلیدی
ویروس واریسلا زوستر، سینه بند، لووتیروکسین، کم کاری تیروئید،
موضوعات مرتبط
علوم زیستی و بیوفناوری ایمنی شناسی و میکروب شناسی میکروبیولوژی و بیوتکنولوژی کاربردی
چکیده انگلیسی


- It has been shown previously that hypothyroidism patients are predisposed to herpes zoster.
- It was hypothesized that patients taking thyroid hormone medication will exhibit a reduced occurrence of shingles.
- The present study indicates that hypothyroidism patients taking medicines have a lower risk of shingles.
- This risk reduction applies to all age groups, with female patients exhibiting the most significant benefit.
- This study suggests that hypothyroidism may be a risk factor for varicella zoster virus reactivation.

SummaryObjectiveThyroid hormone (TH) has been suggested to control herpes virus gene expression and replication in neurons via epigenetics through its nuclear receptors. It has previously been shown that patients with hypothyroidism are predisposed to herpes zoster (HZ), suggesting that the TH deficiency may be a risk factor for varicella zoster virus (VZV) reactivation. The aim of this study was to test the hypothesis that TH treatment will ameliorate the complication of HZ.MethodsThis study investigated the hypothesis by enquiring into a comprehensive medical database at Kaiser Permanente Southern California (KPSC) to verify whether patients taking TH medication experience a reduction in HZ occurrence.ResultsIt was shown by Kaplan-Meier analysis that hypothyroidism patients taking TH medicines had a lower risk of HZ. The fully adjusted analysis indicated that patients receiving medication for the treatment of TH deficiency exhibited a reduced risk of HZ (hazard ratio 0.60, 95% confidence interval 0.51-0.71). This lower risk of HZ was significant in all age groups except the 18-39 years cohort. In addition, female patients taking TH treatment exhibited a lower risk than their male counterparts.ConclusionsTogether these findings support the hypothesis that a constant level of TH will provide a degree of protection from contracting HZ. More studies are underway to evaluate the laboratory data for an analysis of hormonal effects on individuals.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: International Journal of Infectious Diseases - Volume 59, June 2017, Pages 90-95
نویسندگان
, , ,